-- On September 19, 2019, the New York-located company BOC Sciences released a series of efficient lead discovery tactics and services, encompassing high-throughput screening, hit identification, hit to lead, lead optimization as well as chemical resynthesis, for scientists who are devoted to drug design and optimization endeavors. With the hope to ease their burden and R&D stress, this company has been actively involved with pharmaceutical industry over the past two years.
It is an admitted truth that drug discovery and design process is hugely complicated, expensive and time-consuming, yet no one hundred percent of success rate is guaranteed or ensured. Therefore, each and every step in drug development should be carefully conducted and monitored. As the initial step of the whole process, lead discovery plays a deciding role in determining the success of a drug development project.
“Once a target, generally an enzyme or receptor, has been specified, medicinal experts will strive to find, neither by discovery or chemical synthesis, compounds that interact with those targets. After several rounds of screening, testing and analyzing, some compounds complying with the selection standards will be chosen out, called ‘leads’. These leads then will be further investigated and optimized to have better activity, selectivity, and biological behavior,” says Mr. Barron Jones, the Marketing Chief of BOC Sciences. “Although the lead discovery process is also complex that entails lots of detailed work, the major tasks involved include hit identification, lead generation, lead optimization and chemical resynthsis.”
Hit identification and lead generation
The very first step is to search for promising hits. The most commonly use tools are library screening, including traditional library screening and those newly emerging libraries like fragment-based library, virtual screening or high-throughput screening. In libraries, there are not only traditional compounds with potentially high activity molecules, but also virtual molecules tested through molecular modeling simulations. When the screening process is finished, a small portion of potent hits will be identified. And finally, promising lead compounds are explicated and the analogs are synthesized.
Lead optimization
Through lead optimization, the specificity, selectivity, pharmacodynamics, pharmacokinetics, and toxicology of targets are optimized. To produce the best preclinical drug candidates, approaches like alterations of the chemical structure of compounds are utilized. Factors that should be taken into consideration in optimizing leads include like potency, duration, bioavailability, safety and drug acceptability.
“Advantaged by interdisciplinary scientists, robust compounds libraries and advanced screening techniques, we are confident that we would be the best choice for lead discovery as well as other R&D related endeavors that cover the whole process of drug discovery and development,” further adds Mr. Jones.
For more information, please visit https://www.solutions.bocsci.com.
About BOC Sciences
As a trust-worthy brand, BOC Sciences is committed to offering strategies and solutions to help resolve the most urgent and pressing issues surfaced in drug development industry. Aiming high, BOC Sciences provides comprehensive early drug discovery CRO services that covers medicinal chemistry and custom synthesis all the way to drug analysis, purification and formulation, using its state-of-the-art techniques and equipment.
Contact Info:
Name: Alex Green
Email: Send Email
Organization: BOC Sciences
Address: 45-16 Ramsey Road, Shirley, NY 11967, USA
Phone: 1-631-619-7922
Website: https://www.solutions.bocsci.com
Release ID: 88920487
Google
RSS